Catégories
Non classé

METACRYSTAL showcase at recent prestigious international conferences

IEEE NSS/MIC (Nuclear Sciences Symposium and Medical Imaging Conference), Tampa (USA), 28 October – 2 November 2024

This conference is the major annual event for nuclear radiation instrumentation with a special focus on nuclear medical imaging. METACRYSTAL has been particularly illustrated at the 2024 issue in Tampa, Florida, with the Valentin T. Jordanov Radiation Instrumentation Travel Grant, attributed to Dr. Ricardo LATELLA, former chief engineer at METACRYSTAL, and the prestigious Ed. Hoffman Medical Imaging Scientist Award presented to Prof. Paul LECOQ.

PICOSEC Workshop, Isola d’Elba (Italy), 19 – 23 May 2025

This workshop, the 14th of a series initiated in 2005 by the University of Chicago and then the University of Kansas City, addressed particularly the latest developments on Ultra Fast timing from 1-50 picosecond levels becoming achievable with the new technological development on scintillating crystals, photodetectors and readout electronics. The philosophy of this workshop follows the ones organized in Chicago (2005, 2006, 2008 and 2011), Saclay (2007), Clermont Ferrand (2009), Cracow (2010), Clermont-Ferrand (2014), Prague (2015), Kansas City (2016), Torino (2018), Zurich (2021) and Elba (2023). Prof. Paul LECOQ, member of the International Organizing Committee, was invited to present the two following talks:

  • 10ps Time-of-Flight PET scanner: The Odyssey From Hope to Practice
  • Harnessing the Purcell Effect for Faster Metascintillators

International Conference on Materials Science, Engineering & Technology, Paris (France), 28 – 30 May 2025

Organised by the North Central College (USA) this conference fosters international collaboration and knowledge exchange among academics, researchers, professionals, and industry leaders in the fields of material science, physics, chemistry, and biology. Prof. Paul LECOQ was invited to give the introductory talk in the first plenary session of this important event, with the following title: “Metascintillators for Medical Imaging Applications”.

ANIMMA, 9th International conference on Advancements in Nuclear Instrumentation Measurement Methods and their Applications, Valencia (Spain), 9 – 13 June 2025

At this important event, which gathers every second year the large academic and industrial community working on nuclear instrumentation, Prof. Paul Lecoq, member of the scientific committee, introduced the sessions on nuclear medical imaging applications with the following invited talk: “Future Trends in Nuclear Medical Imaging” where he mentioned his interest and involvement for the deployment of modern, cost-effective early diagnostic tools, such as gamma cameras, SPECT and PET scanners, in low- and medium-income countries (LMICs), representing 2/3 of the world population, having presently no access to them, with a strong societal and economical impact. A resolution has been formally presented by Prof. John Prior, head of the nuclear medicine department at the university hospital in Lausanne and accepted in February 2025 at the general assembly of the World Health Organisation (WHO) in Geneva and is supported by the International Atomic Energy Agency in Vienna.

Catégories
Non classé

Press release #1

Multiwave Technologies AG

Following 5 years of R&D under the Multiwave umbrella, Multiwave Technologies AG has sold on 1st October 2024, its wholly owned subsidiary, Multiwave Metacrystal SA, to a consortium of ex-CERN physicists and a business developer, led by Dr Paul Lecoq, for an undisclosed amount. The company which will operate now as Metacrystal SA, has developed a radically new metascintillator technology, providing a quantum leap in scintillator timing performance.

About Multiwave Technologies AG :

Multiwave Technologies AG is a deep tech medical device company developing an AI-powered portable MRI device. The Company used its software tools and know-how to contribute to Metacrystal’s first scientific milestones. We wish Metacrystal’s new management all the best in their journey to make PET imaging safer.

About Metacrystal SA :

Under the leadership of Professor Paul Lecoq, Metacrystal’s ambition is to introduce its disruptive technology in ionizing radiation detectors across a broad application spectrum. In particular, strong benefits are expected for PET (Positron Emission Tomography) Scanners in medical imaging, both by improving diagnosis at early stages of a disease and by reducing the dose injected to the patient, increasing therefore the patient base to pregnant women and children. All these improvements will reduce the cost of nuclear medicine imaging infrastructures and protocols.